drugset / Trial / NCT01930461

Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma

NCT01930461 ↗

Phase 2 Completed 386 enrolled Stallergenes Greer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to investigate the efficacy and safety of different doses of sublingual tablets of house dust mite allergen extracts as compared to placebo in adults with house dust mite-associated allergic asthma.

Timeline

Start
2013-09
Primary completion
2015-06
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject SLIT tablets of HDM allergen extracts Unknown — Other

Indications